Member Info for Toukankahmoon

I refer you to my posts after the December briefing in which I questioned rate of AVA6000 cleaving versus rate of cleaved fox being excreted. The AVA6000 half life in the bloodstream is very short. I said that I thought the variable results in patients was a strong reason to delay P1a to insert a 2 weekly trial in the expectation that this would improve results to the extent that BP or IIs would be convinced enough to invest.

The Pom Pom girls poo pood this suggestion but I still feel that this was the main reason for the change in strategy. I think and hope that arm2 will give us the results we need but it is far from being a slam dunk and that is why we are where we are.

Al is the king of the ambiguous communication especially if it allows him to big up the prospects of Avacta. You have only yourselves to blame if you chose to read Al’s words in the best possible light and then over invest.

Bdoggg

Confident based on what? Reading tea leaves?

Hje306

Most investors would think of it as a support level. If you think about what investors were doing when it last hit that level then it’s obvious why it is regarded as such.

TT23

And you think that this “group” is much better when one posts something that upsets the Pom Pom wavers narrative???😄

Thorn

Concur. Providing all goes well which is by no means a gimme. The arm 2 results need to be strong

So Al was lying when he set out the plans for the next two years?

Ice

This is just the sort of inflammatory post that ruins this BB

Yep and suspend those who continually make personal attacks against other BB members and submit potty mouthed posts.

“Avacta could easily solve sentiment overnight by doing a media campaign, however I feel they have more important things to do at the moment”

Jeez we are really in trouble if the PR team are let lose with test tubes🤣🤣🤣

The former judging by what is happening with AVA6000 but I’m sure someone will correct me.

Predicting an outcome is only as accurate as the information being analysed. Nuff said.

Bring back technical analysis at least that has a basis in statistics 🤣

Nice to see the Pom Pom girls displaying their vast intellect

Gje306

That’s because I’m not glued to this BB 24/7

I gave you my honest opinion that after waiting so long with expectations running so high that I was disappointed. Like a lot of people on here. At that point you obviously stopped reading what I said next.

I still don’t understand why you and some others are hell bent on finding things to row about and resorting to personal attacks is just crazy.

Pom Pom girls have been talking about imminent deals for months if not years and like all their wishful thinking nothing has happened.

Al has said no deals for AVA6000 and at least arm 2 data needed for the likes of AVA3996 deals. Don’t you rampers ever give up and just wait patiently.

Hje306

Oh but hold on. The views you aired in your post at 15:43 are incredibly similar to views I posted weeks ago and was roundly criticised by the Pom Pom girls on here.

Gje306

Pardon me. I thought you genuinely wanted other peoples opinions rather than bating people so you could do your usual belittling tactics. Leopard never changes its spots

Issue is that there is little or no independent information to research and Al is the master of ambiguity.

Gje306

Before you start, I am not cj62 but I don’t think I can tell whether the P1a results are good or not. On their own they aren’t but they don’t preclude great efficacy with targeted patients and more frequent dosing regime. So we just have to wait for arm 2 results to give us a better idea. IMHO

You talk of maximum lifetime dose for dox. But what does that actually mean for AVA6000 where “free” dox in the bloodstream is much lower. I would have thought that it blows conventional MLT out of the water?

3996 sorts the funding for Al